ClinPlus Weekly Wrap

  1. A site’s responsibility in tracking recruitment initiatives  Discussion about methods and professionalizing patient recruitment and the importance of metrics that identify which approaches result in reaching enrollment goals within the contracted time frame. 2. Expansions of in-house R&D will have no impact on CROs, say Pfizer and Lilly Despite expanding their in-house R&D facilities, both Pfizer […]

Clinplus Weekly Wrap

  1. Top 6 Reasons for Phase III Trial Failures A slideshow with explanation of the top 6 reasons why Phase III Trials can result in failure. 2. Funds Join Campaign to Pressure Pharma to Disclose Trial Data Data transparency has gotten a lot of attention and now a large group is joining a non-profit campaign in […]

ClinPlus Weekly Wrap

1. Targeting eTMF for efficiency and productivity gains This article stresses the importance of coordination and control of clinical trial documentation while following Good Clinical Practices (GCP).   2. Critical elements of patient centricity Defining patient centricity in clinical trials is difficult, but here it is defined and discussed in depth, focusing on necessary changes to become patient […]

ClinPlus Weekly Wrap

  1. Quality Metrics for Clinical Trials This article brings up the very controversial topic of clinical trial quality and presents a case study reviewing Pfizer’s quality metrics and other related procedures. 2. Clinical Study Sponsors Outsource an Average of 68% of Data Management Responsibilities per Trial, According to Cutting Edge Information In depth study of […]